
Harbor Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10
Best for: compounded GLP-1 with steep prepay discounts (sema $99/mo on 12 months) and flat dose pricing
Harbor scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
Price checked on Harbor’s site,
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Harbor (now rebranding as Arbor) is a LegitScript-certified telehealth platform where board-certified physicians from MD Integrations prescribe compounded semaglutide and tirzepatide as weekly injections. Month-to-month plans are $199/mo for semaglutide and $299/mo for tirzepatide, at the same price at every dose; 6- and 12-month prepay plans cut that to $99 and $149 a month. Plans include clinician care, refills and shipping, with dietitian support after treatment.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Harbor
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
Harbor at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Harbor
Each dimension is scored algorithmically from Harbor’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.6/10At $199/mo, Harbor runs about 11% above the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.5/10Harbor offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
8.2/10Online intake and platform experience (ongoing clinician messaging, consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.7/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.9/10Harbor's exact state footprint isn't published. Confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
6.8/10Clinician messaging between visits.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Harbor review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199–$299/mo across 2 dose/plan tiers (checked October 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Harbor
We walked Harbor’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Click Get My Personalized Plan to open the online quiz (described as about 90 seconds).
- 2The first quiz screen asks for your height and weight (we stopped here).
- 3A licensed U.S. clinician reviews your answers, usually within 24-48 hours; some states require a live audio or video visit.
- 4If approved, medication ships by FedEx Express within about 48 hours.
- 5Ongoing physician check-ins and refills, then optional dietitian support after the medication phase.
- Advertised prices vary by page ($89, $99 or $119 to $149) and are prepay rates; the plan data shows $199 and $299 month-to-month.
- The $89 and $119 figures on the homepage and semaglutide page match no plan in the site's own product data.
- Refund terms are strict: a $100 clinician fee if you cancel before the prescription, and no refund after it is written.
- The money-back guarantee needs 12 months of continuous enrollment.
- The site is mid-rename from Harbor to Arbor; the patient portal runs on MD Integrations.
- Text support is published; email is listed for accessibility requests.
Harbor customer support
- Phone
- +1 (332) 205-9094
GLP-1 medications Harbor offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$199/mo month-to-month. Longer plans: 3-mo $199/mo ($597), 6-mo $109/mo ($654), 12-mo $99/mo ($1,188 upfront).
$299/mo month-to-month. Longer plans: 3-mo $299/mo ($897), 6-mo $169/mo ($1,014), 12-mo $149/mo ($1,788 upfront).
Ready to get started?
Plans and promotions change often, so check Harbor's current pricing and active discounts before you decide.
What we like
- Big prepay discounts: semaglutide drops to $99/mo and tirzepatide to $149/mo on a 12-month plan
- Same price at every dose, with no membership fee
- Named board-certified physicians, with 24/7 clinical messaging through the patient portal
- Free 48-hour FedEx shipping after approval
- Full refund if a clinician does not approve treatment
- HSA/FSA cards accepted; dietitian support after the medication phase
Watch-outs
- Headline "from $89" or "$99/mo" prices are not month-to-month; monthly billing is $199 (sema) or $299 (tirz)
- Once a prescription is written, payment is non-refundable, even for unshipped prepaid months
- Canceling before a prescription is written still costs a $100 clinician fee
- The money-back guarantee requires 12 months of continuous enrollment and meeting program rules
- Compounded medications are not FDA-approved; pharmacy partners are not named
- No published state list; some states require a live audio or video visit
- Brand is mid-rename to Arbor, so names differ across the site and portal
Is Harbor worth it?
The short version of what Harbor offers is compounded GLP-1 with steep prepay discounts (sema $99/mo on 12 months) and flat dose pricing. It runs $199/month at every dose, squarely in the middle of what this category charges, so what you get for it matters more here than the number itself. Its flat, all-dose pricing helps anyone worried about cost climbing as they titrate up.
It is LegitScript-certified. It also offers round-the-clock messaging and takes HSA/FSA payment.
How much Harbor costs
Compounded semaglutide runs $199/month and compounded tirzepatide runs $299/month.
That's roughly in line with the ~$179/month median across the GLP-1 providers we track (each program's lowest listed ongoing monthly price for compounded semaglutide).
For a direct comparison, MadeMed runs semaglutide and tirzepatide from $179/month, so compare it with Harbor before you commit.
Medications: what Harbor prescribes
Harbor prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who Harbor is best for, and who should skip it
A good fit if you…
- value being able to message a clinician between visits instead of waiting on the next scheduled one.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Harbor offers clinician messaging between visits, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Harbor is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding. If you're comparison-shopping, Belle Health is one of the closest alternatives we track; compare the two before deciding. To see Harbor against the wider field, use our ranked semaglutide providers; the patient guide to compounded versus brand-name GLP-1s covers what to weigh before choosing a compounded program.
The Bottom Line
Harbor scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with Harbor?
From $199/mo. See current pricing and start your free consultation.
Harbor might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Harbor vs…
Harbor scores7.8/10
Side-by-side pricing, medications and scores. Pick a matchup.
Harbor vs Amazon One Medical
Amazon One Medical scores 8.5/10

Harbor vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Harbor review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Harbor's current pricing
Plans from $199/mo. Start your free consultation to check eligibility and today's price.